Reevaluation of Systemic Early Neuromuscular Blockade ROSE

810110
Jay Steingrub, MD

Baystate Medical Center

759 Chestnut Street

Springfield, MA  01199

The purpose of the study is to assess the efficacy and safety of early neuromuscular blockade in reducing mortality and morbidity in patients with moderate-severe ARDS in comparison to a control group with no routine early neuromuscular blockade.

To be eligible, patients must be 18 years of age or older and be experiencing moderate-severe acute respiratory distress syndrome.
Lori-Ann Kozikowski
413-794-4889